Merck & Co., Inc. (NYSE:MRK) ranks among the best magic formula stocks to invest in. On July 10, UBS reiterated its Buy ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

RBC Capital analyst Paul Treiber maintained a Hold rating on Open Text on July 22 and set a price target of $30.00. The company’s shares closed yesterday at $30.22. Take advantage of TipRanks Premium ...

Freshfields’ senior partner, Georgia Dawson, has been elected to serve a second term as senior partner alongside a ...

As Merck gears up for its Q2 earnings, all eyes are on Keytruda, its oncology superstar. Keytruda, accounting for nearly half of Merck’s pharma sales, is anticipated to report Q2 sales of $7.90 ...